UTM Stock Overview
Develops, manufactures, and distributes medical devices for the healthcare industry worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for UTM from our risk checks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Utah Medical Products, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$57.00 |
| 52 Week High | US$69.00 |
| 52 Week Low | US$56.00 |
| Beta | 0.081 |
| 1 Month Change | -3.39% |
| 3 Month Change | -5.00% |
| 1 Year Change | -13.64% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 154.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| UTM | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -2.6% | -2.4% | -0.6% |
| 1Y | -13.6% | -4.7% | 14.8% |
Return vs Industry: UTM underperformed the German Medical Equipment industry which returned -4.7% over the past year.
Return vs Market: UTM underperformed the German Market which returned 14.8% over the past year.
Price Volatility
| UTM volatility | |
|---|---|
| UTM Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 6.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: UTM has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: UTM's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 180 | Kevin Cornwell | www.utahmed.com |
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies.
Utah Medical Products, Inc. Fundamentals Summary
| UTM fundamental statistics | |
|---|---|
| Market cap | €195.17m |
| Earnings (TTM) | €13.26m |
| Revenue (TTM) | €39.10m |
14.7x
P/E Ratio5.0x
P/S RatioIs UTM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| UTM income statement (TTM) | |
|---|---|
| Revenue | US$40.90m |
| Cost of Revenue | US$16.76m |
| Gross Profit | US$24.14m |
| Other Expenses | US$10.27m |
| Earnings | US$13.87m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.09 |
| Gross Margin | 59.03% |
| Net Profit Margin | 33.92% |
| Debt/Equity Ratio | 0% |
How did UTM perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield30%
Payout RatioDoes UTM pay a reliable dividends?
See UTM dividend history and benchmarks| Utah Medical Products dividend dates | |
|---|---|
| Ex Dividend Date | Mar 14 2025 |
| Dividend Pay Date | Apr 03 2025 |
| Days until Ex dividend | 19 days |
| Days until Dividend pay date | 39 days |
Does UTM pay a reliable dividends?
See UTM dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/22 21:08 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Utah Medical Products, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Munda | Sidoti & Company, LLC |